PaxMedica, Common Stock Price on April 6, 2023

PXMDDelisted Stock  USD 0.86  0.18  17.31%   
If you're considering investing in PaxMedica, Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of PaxMedica, Common stands at 0.86, as last reported on the 2nd of December, with the highest price reaching 1.05 and the lowest price hitting 0.77 during the day. We have found twenty-three technical indicators for PaxMedica, Common Stock, which you can use to evaluate the volatility of the company. Please check PaxMedica, Common's Risk Adjusted Performance of (0.15), variance of 23.93, and Coefficient Of Variation of (492.32) to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
PaxMedica, Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PXMD
Based on monthly moving average PaxMedica, Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PaxMedica, Common by adding PaxMedica, Common to a well-diversified portfolio.

PaxMedica, Common Valuation on April 6, 2023

It is possible to determine the worth of PaxMedica, Common on a given historical date. On April 6, 2023 PaxMedica, was worth 1.9 at the beginning of the trading date compared to the closed value of 1.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PaxMedica, Common pink sheet. Still, in general, we apply an absolute valuation method to find PaxMedica, Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PaxMedica, Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PaxMedica, Common's related companies.
 Open High Low Close Volume
  2.02    2.03    1.90    1.95    331,525  
04/06/2023
  1.90    1.92    1.82    1.89    306,200  
  1.79    1.79    1.61    1.72    448,620  
Backtest PaxMedica, Common  |  PaxMedica, Common History  |  PaxMedica, Common Valuation   PreviousNext  
Open Value
1.9
1.89
Closing Value
1.90
Upside

PaxMedica, Common Trading Date Momentum on April 6, 2023

On April 10 2023 PaxMedica, Common Stock was traded for  1.72  at the closing time. The top price for the day was 1.79  and the lowest listed price was  1.61 . The trading volume for the day was 448.6 K. The trading history from April 10, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 8.99% . The trading delta at closing time against the current closing price is 7.41% .

PaxMedica, Common Stock Fundamentals Correlations and Trends

By evaluating PaxMedica, Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PaxMedica, Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PaxMedica, financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About PaxMedica, Common Pink Sheet history

PaxMedica, Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PaxMedica, is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PaxMedica, Common Stock will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PaxMedica, Common stock prices may prove useful in developing a viable investing in PaxMedica, Common
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC. Paxmedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.

PaxMedica, Common Pink Sheet Technical Analysis

PaxMedica, Common technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of PaxMedica, Common technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of PaxMedica, Common trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

PaxMedica, Common Period Price Range

Low
December 2, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

PaxMedica, Common Stock cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

PaxMedica, Common December 2, 2024 Market Strength

Market strength indicators help investors to evaluate how PaxMedica, Common pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PaxMedica, Common shares will generate the highest return on investment. By undertsting and applying PaxMedica, Common pink sheet market strength indicators, traders can identify PaxMedica, Common Stock entry and exit signals to maximize returns

PaxMedica, Common Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for PaxMedica, Common's price direction in advance. Along with the technical and fundamental analysis of PaxMedica, Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of PaxMedica, to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Consideration for investing in PaxMedica, Pink Sheet

If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios